A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation. (1990)
Lund J, Tanaka T, Takahashi N, Sarmay G, Arata Y, Jefferis R
Mol Immunol, 1990 vol.27:1145-1153
SNFG,
Text,
Oxford
taxonomy (1)
protein (1)
source (1)
structure (8)
composition (7)
disease (1)
reference (1)
site (1)
peptide (0)
- J558L (CVCL_3949)
Source
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
Reported structure
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:7 HexNAc:4 (avg mass : 1965.7921 )
- Hex:7 HexNAc:4 dHex:1 (avg mass : 2111.9351 )
Composition
- Myeloma (DOID:0070004)
Disease
-
Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
Reported glycosite
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1463.3655)
- J558L (CVCL_3949)
- Myeloma (DOID:0070004)
-
Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1625.5079)
- J558L (CVCL_3949)
- Myeloma (DOID:0070004)
-
Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1625.5079)
- J558L (CVCL_3949)
- Myeloma (DOID:0070004)
-
Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1641.5073)
- J558L (CVCL_3949)
- Myeloma (DOID:0070004)
-
Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1787.6503)
- J558L (CVCL_3949)
- Myeloma (DOID:0070004)
-
Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1949.7927)
- J558L (CVCL_3949)
- Myeloma (DOID:0070004)
-
Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1965.7921)
- J558L (CVCL_3949)
- Myeloma (DOID:0070004)
-
Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2111.9351)
- J558L (CVCL_3949)
- Myeloma (DOID:0070004)
-
Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2111.9351)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1965.7921)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1641.5073)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1625.5079)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1625.5079)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1463.3655)